| NCT03233074 |
Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors |
https://ClinicalTrials.gov/show/NCT03233074 |
Recruiting |
Institut de Cancérologie de la Loire |
2020-09-30 |
| NCT03363399 |
Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT03363399 |
Completed |
University Hospital, Grenoble |
2018-09-06 |
| NCT03107273 |
Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes. |
https://ClinicalTrials.gov/show/NCT03107273 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2018-01-23 |
| NCT03072498 |
Collection of Samples From Patients With MDS |
https://ClinicalTrials.gov/show/NCT03072498 |
Recruiting |
PersImmune, Inc |
2020-12-05 |
| NCT02921815 |
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment |
https://ClinicalTrials.gov/show/NCT02921815 |
Active, not recruiting |
Celgene |
2020-06-19 |
| NCT02921802 |
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules |
https://ClinicalTrials.gov/show/NCT02921802 |
Active, not recruiting |
Celgene |
2020-06-19 |
| NCT02891551 |
An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands |
https://ClinicalTrials.gov/show/NCT02891551 |
Completed |
Celgene |
2016-06-30 |
| NCT02842229 |
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms |
https://ClinicalTrials.gov/show/NCT02842229 |
Completed |
Celgene |
2017-02-02 |
| NCT02804984 |
Identification of Molecular Defects in Idiopathic Cytopenia of Undetermined Significance |
https://ClinicalTrials.gov/show/NCT02804984 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2019-07-31 |
| NCT02775383 |
The National Myelodysplastic Syndromes (MDS) Study |
https://ClinicalTrials.gov/show/NCT02775383 |
Recruiting |
National Heart, Lung, and Blood Institute (NHLBI) |
2021-09-30 |
| NCT02767388 |
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery |
https://ClinicalTrials.gov/show/NCT02767388 |
Completed |
University of Nebraska |
2017-12-11 |
| NCT02598752 |
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation |
https://ClinicalTrials.gov/show/NCT02598752 |
Completed |
Memorial Sloan Kettering Cancer Center |
2020-04-10 |
| NCT00923442 |
Biology Studies of Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00923442 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02378701 |
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease |
https://ClinicalTrials.gov/show/NCT02378701 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2023-02-28 |
| NCT02390414 |
The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study |
https://ClinicalTrials.gov/show/NCT02390414 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2023-05-31 |
| NCT02291965 |
Blood Samples to Identify Biomarkers of Busulfan |
https://ClinicalTrials.gov/show/NCT02291965 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2019-04-20 |
| NCT02269592 |
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome |
https://ClinicalTrials.gov/show/NCT02269592 |
Recruiting |
Dana-Farber Cancer Institute |
2024-12-31 |
| NCT02262312 |
Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT02262312 |
Completed |
Zealand University Hospital |
2015-06-30 |
| NCT02164071 |
Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT02164071 |
Completed |
Celgene |
2013-12-03 |
| NCT02137629 |
Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea |
https://ClinicalTrials.gov/show/NCT02137629 |
Completed |
Celgene |
2016-05-19 |
| NCT02085798 |
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) |
https://ClinicalTrials.gov/show/NCT02085798 |
Completed |
Celgene |
2015-08-31 |
| NCT02060409 |
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT02060409 |
Completed |
Samsung Medical Center |
2013-10-31 |
| NCT01311258 |
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01311258 |
Recruiting |
University of Rochester |
2020-08-31 |
| NCT02057185 |
Occupational Status and Hematological Disease |
https://ClinicalTrials.gov/show/NCT02057185 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2019-03-31 |
| NCT01956799 |
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy |
https://ClinicalTrials.gov/show/NCT01956799 |
Active, not recruiting |
Fondazione Italiana Sindromi Mielodisplastiche Onlus |
2018-07-31 |
| NCT01951430 |
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients |
https://ClinicalTrials.gov/show/NCT01951430 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01929408 |
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients |
https://ClinicalTrials.gov/show/NCT01929408 |
Completed |
Fred Hutchinson Cancer Research Center |
2018-12-04 |
| NCT01911871 |
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations |
https://ClinicalTrials.gov/show/NCT01911871 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-10-31 |
| NCT01855698 |
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT01855698 |
Completed |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-03-15 |
| NCT01793675 |
Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01793675 |
Completed |
Peking University People’s Hospital |
2012-12-31 |
| NCT01739452 |
Spanish Registry of Erythropoietic Stimulating Agents Study |
https://ClinicalTrials.gov/show/NCT01739452 |
Completed |
Grupo Español de SÃndromes Mielodisplásicos |
2014-05-31 |
| NCT01728402 |
Pathogenesis of Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01728402 |
Enrolling by invitation |
OHSU Knight Cancer Institute |
2020-10-31 |
| NCT01688011 |
Connect® MDS/AML Disease Registry |
https://ClinicalTrials.gov/show/NCT01688011 |
Recruiting |
Celgene |
2022-12-12 |
| NCT01595295 |
Registry on Hypomethylating Agents in Myeloid Neoplasms |
https://ClinicalTrials.gov/show/NCT01595295 |
Recruiting |
Arbeitsgemeinschaft medikamentoese Tumortherapie |
2020-06-30 |
| NCT01409070 |
Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01409070 |
Completed |
Seoul National University Hospital |
2011-12-31 |
| NCT01400633 |
An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01400633 |
Completed |
Janssen Korea, Ltd., Korea |
2014-03-31 |
| NCT01355913 |
Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells |
https://ClinicalTrials.gov/show/NCT01355913 |
Completed |
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH |
2016-10-31 |
| NCT01347944 |
MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry |
https://ClinicalTrials.gov/show/NCT01347944 |
Completed |
Celgene |
2013-06-30 |
| NCT04428489 |
Follow-up Study of ICUS and CCUS Patients |
https://ClinicalTrials.gov/show/NCT04428489 |
Enrolling by invitation |
The First Affiliated Hospital of Soochow University |
2020-12-31 |
| NCT04326023 |
Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB) |
https://ClinicalTrials.gov/show/NCT04326023 |
Completed |
University Hospital, Caen |
2020-03-18 |
| NCT04296214 |
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT04296214 |
Recruiting |
Grupo Cooperativo de HemopatÃas Malignas |
2021-12-31 |
| NCT04251078 |
Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples |
https://ClinicalTrials.gov/show/NCT04251078 |
Recruiting |
Josep Carreras Leukaemia Research Institute |
2020-12-31 |
| NCT04174547 |
An European Platform for Translational Research in Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT04174547 |
Recruiting |
Istituto Clinico Humanitas |
2021-09-30 |
| NCT04060485 |
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results |
https://ClinicalTrials.gov/show/NCT04060485 |
Recruiting |
National Taiwan University Hospital |
2024-08-31 |
| NCT03894852 |
SRSF2 Gene Mutation in Patients With t-MDS/AML |
https://ClinicalTrials.gov/show/NCT03894852 |
Completed |
Assiut University |
2019-12-29 |
| NCT03659084 |
Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03659084 |
Recruiting |
Hospices Civils de Lyon |
2018-04-30 |
| NCT03621241 |
MODIFY (Mds DIagnosis Flow cYtometry) |
https://ClinicalTrials.gov/show/NCT03621241 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2021-06-15 |
| NCT03526926 |
A Post-Marketing Observational Study of VYXEOSâ„¢ |
https://ClinicalTrials.gov/show/NCT03526926 |
Active, not recruiting |
Jazz Pharmaceuticals |
2020-01-31 |
| NCT03469661 |
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT03469661 |
Recruiting |
Fundacion CRIS de Investigación para Vencer el Cáncer |
2020-04-30 |
| NCT01252485 |
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project |
https://ClinicalTrials.gov/show/NCT01252485 |
Recruiting |
University of Ulm |
NA |
| NCT01241357 |
High-Tc Susceptometer to Monitor Transfusional Iron Overload |
https://ClinicalTrials.gov/show/NCT01241357 |
Completed |
Columbia University |
2015-10-31 |
| NCT01199562 |
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01199562 |
Completed |
City of Hope Medical Center |
2013-12-31 |
| NCT01192945 |
Non-interventional Study With Azacitidin (Vidaza®) |
https://ClinicalTrials.gov/show/NCT01192945 |
Completed |
iOMEDICO AG |
2014-12-31 |
| NCT01146210 |
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01146210 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01141959 |
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients |
https://ClinicalTrials.gov/show/NCT01141959 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-12-31 |
| NCT01137825 |
Registry of Older Patients With Cancer |
https://ClinicalTrials.gov/show/NCT01137825 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2030-06-30 |
| NCT01137643 |
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT01137643 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2040-07-31 |
| NCT01135849 |
B-Receptor Signaling in Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT01135849 |
Completed |
Stanford University |
2010-10-31 |
| NCT01099267 |
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003 |
https://ClinicalTrials.gov/show/NCT01099267 |
Completed |
Celgene |
2010-10-01 |
| NCT01095874 |
Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study |
https://ClinicalTrials.gov/show/NCT01095874 |
Completed |
Saint-Louis Hospital, Paris, France |
2014-01-31 |
| NCT01041846 |
A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01041846 |
Completed |
Janssen Korea, Ltd., Korea |
2010-07-31 |
| NCT00996047 |
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers |
https://ClinicalTrials.gov/show/NCT00996047 |
Completed |
Southwest Oncology Group |
2012-01-31 |
| NCT00993694 |
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone |
https://ClinicalTrials.gov/show/NCT00993694 |
Completed |
Vanderbilt University Medical Center |
2009-12-31 |
| NCT00987584 |
Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk |
https://ClinicalTrials.gov/show/NCT00987584 |
Completed |
Stanford University |
2011-01-31 |
| NCT00967564 |
Survey on QUality of Life In myeloDisplasia (SQUID) |
https://ClinicalTrials.gov/show/NCT00967564 |
Completed |
Janssen-Cilag S.p.A. |
2009-11-30 |
| NCT00964821 |
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00964821 |
Completed |
City of Hope Medical Center |
2013-05-31 |
| NCT00954720 |
Observational Study of Iron Overload in Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00954720 |
Completed |
Dana-Farber Cancer Institute |
2011-01-31 |
| NCT00919425 |
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00919425 |
Completed |
Southwest Oncology Group |
2012-01-31 |
| NCT00909467 |
Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases |
https://ClinicalTrials.gov/show/NCT00909467 |
Completed |
Medical University of Graz |
2011-11-30 |
| NCT00900406 |
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00900406 |
Completed |
Vanderbilt-Ingram Cancer Center |
2010-03-31 |
| NCT00899795 |
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00899795 |
Completed |
OHSU Knight Cancer Institute |
2010-10-31 |
| NCT00899665 |
Proteases in Patients With Prostate Cancer That Has Spread to the Bone |
https://ClinicalTrials.gov/show/NCT00899665 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2006-09-30 |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00899223 |
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00899223 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2020-12-31 |
| NCT01362985 |
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor |
https://ClinicalTrials.gov/show/NCT01362985 |
Completed |
Sanofi |
2014-07-31 |
| NCT03558386 |
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT03558386 |
Completed |
Center for International Blood and Marrow Transplant Research |
2019-11-15 |
| NCT00809575 |
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00809575 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-10-08 |
| NCT04263181 |
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration |
https://ClinicalTrials.gov/show/NCT04263181 |
Recruiting |
Washington University School of Medicine |
2025-01-31 |
| NCT02188290 |
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation |
https://ClinicalTrials.gov/show/NCT02188290 |
Completed |
Kiadis Pharma |
2015-06-30 |
| NCT03526666 |
Ascorbic Acid Levels in MDS, AML, and CMML Patients |
https://ClinicalTrials.gov/show/NCT03526666 |
Completed |
Van Andel Research Institute |
2018-10-31 |
| NCT00764829 |
Blood Samples to Evaluate Biomarkers of Donor Chimerism |
https://ClinicalTrials.gov/show/NCT00764829 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-02-29 |
| NCT00723112 |
The Role of Erythropoietin in Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00723112 |
Completed |
University of Utah |
2010-10-31 |
| NCT00682799 |
Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC) |
https://ClinicalTrials.gov/show/NCT00682799 |
Completed |
University Hospital Freiburg |
2013-03-31 |
| NCT00662090 |
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood |
https://ClinicalTrials.gov/show/NCT00662090 |
Recruiting |
University Hospital Freiburg |
2019-12-31 |
| NCT00606216 |
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy |
https://ClinicalTrials.gov/show/NCT00606216 |
Completed |
Memorial Sloan Kettering Cancer Center |
2015-12-31 |
| NCT00600860 |
A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00600860 |
Recruiting |
Radboud University |
2020-06-30 |
| NCT00569842 |
Investigation of the Cylex® ImmuKnow® Assay |
https://ClinicalTrials.gov/show/NCT00569842 |
Completed |
Indiana University |
2010-02-28 |
| NCT00525746 |
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) |
https://ClinicalTrials.gov/show/NCT00525746 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2025-03-31 |
| NCT00511537 |
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders |
https://ClinicalTrials.gov/show/NCT00511537 |
Completed |
University of California, San Francisco |
2009-06-30 |
| NCT00510315 |
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00510315 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT00504920 |
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients |
https://ClinicalTrials.gov/show/NCT00504920 |
Completed |
M.D. Anderson Cancer Center |
2008-09-30 |
| NCT00499070 |
Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment |
https://ClinicalTrials.gov/show/NCT00499070 |
Completed |
University Hospital Freiburg |
2012-08-31 |
| NCT00481273 |
AVIDA The Vidaza® (Azacitidine) Patient Registry |
https://ClinicalTrials.gov/show/NCT00481273 |
Completed |
Celgene |
2010-08-31 |
| NCT00459524 |
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT00459524 |
Completed |
M.D. Anderson Cancer Center |
2009-03-31 |
| NCT00281814 |
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00281814 |
Completed |
The Cleveland Clinic |
2008-12-31 |
| NCT00281801 |
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation |
https://ClinicalTrials.gov/show/NCT00281801 |
Completed |
Case Comprehensive Cancer Center |
2008-12-31 |
| NCT00195533 |
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients |
https://ClinicalTrials.gov/show/NCT00195533 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-03-31 |
| NCT00126477 |
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00126477 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-04-30 |
| NCT00003790 |
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00003790 |
Completed |
Children’s Oncology Group |
2002-04-30 |
| NCT00048958 |
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT00048958 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00003793 |
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma |
https://ClinicalTrials.gov/show/NCT00003793 |
Completed |
Children’s Oncology Group |
2005-12-31 |